雷火电竞app
CN
EN
CN
EN
ABOUT US
Our Profile
Our Culture
Awards & Recognition
Our History
Our Leadership
SERVICES
R&D Phase
Category
Screening and discovery services
Nonclinical assessment stage
Clinical development stage
Chemical products
Peptide drugs
PROTAC / Molecular Glue
Molecular glues
Biologics
ADCs
Antibody Drugs
Therapeutic vaccines
Prophylactic vaccines
Cell and gene therapeutics
Cell therapy products
Gene therapy products
Nucleic acid drugs
Oncolytic virus drugs
Radiopharmaceuticals
Radiopharmaceutical Drug Development Services
Traditional Chinese medicines
Traditional Chinese medicine innovative medicine
PLATFORM
Technology Platform
Featured Platform
Early druggability assessment stage
Non-clinical Pharmacodynamic Research Platform
Non-clinical Pharmacokinetic Research Platform
Non-clinical Safety Evaluation and Research Platform
Clinical Bioanalysis Platform
Biomarkers and Translational Research Platform
Radioisotope Platform
Integrated Ophthalmology Assessment Platform
Monkey Reproductive Toxicity Assessment Technology Platform
Inhalation Product Assessment Platform
CAREERS
NEWS
Company News
Multimedia Center
CONTACT US
NEWS
Always share our latest news with you
NEWS
ABOUT US
SERVICES
PLATFORM
CAREERS
NEWS
CONTACT US
Company News
Company News
Multimedia Center
Congratulations on the Listing of InnoStar on the STAR Market of Shanghai Stock Exchange
2024-09-03
InnoStar was listed on the STAR Market of Shanghai Stock Exchange on September 3, 2024 (Stock code: 688710).
Last: Congratulations! InnoStar Shanghai and InnoStar Nantong successfully receives the OECD GLP certification
Next: Innostar succefully assisted Signet Therapeutics in the IND approval by U.S. FDA of the world's first targeted drug for the treatment of diffuse gastric cancer
Back
NEWS
Company News
Multimedia Center
News recommendation
2025-04-30
InnoStar Nantong Facility Successfully Passed U.S. FDA GLP Inspection
2024-11-05
Innostar appoints Dr. Sean Xiaochun Chen as CSO
021-60211999
Online consultation
Shanghai Headquarters
Address: 199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, China Postcode: 201203 Tel: +86-21-60211999
Contact us
services@yibang-tech.com
投资者关系
86-021-xxxxxxx
Scan the QR code
Subscription to our Wechat account
股票代码
300012
股 票 代 码
Copyright © 2017-2021©Shanghai InnoStar Bio-tech Co., Ltd. All Rights Reserved. Created By VPABrand.com
Privacy Policy
HOME
ABOUT US
Our Profile
Our Culture
Awards & Recognition
Our History
Our Leadership
SERVICES
R&D Stage
Screening and discovery services
Nonclinical assessment stage
Clinical development stage
Drug type
Chemical products
Biologics
Cell and gene therapeutics
Radiopharmaceuticals
Traditional Chinese medicines
Category
PLATFORM
Technology Platform
Early druggability assessment stage
Non-clinical Pharmacodynamic Research Platform
Non-clinical Pharmacokinetic Research Platform
Non-clinical Safety Evaluation and Research Platform
Clinical Bioanalysis Platform
Biomarkers and Translational Research Platform
Featured platform
Radioisotope Platform
Integrated Ophthalmology Assessment Platform
Monkey Reproductive Toxicity Assessment Technology Platform
Inhalation Product Assessment Platform
Platform introduction
PCC
IND
NDA
Technology Platform
CAREERS
Talent development
JOIN US
Compensation and benefits
Staff demeanor
NEWS
Company News
Multimedia Center
CONTACT US
Shanghai Headquarters
Online Message
